Clinical Trials in Nashville

Showing 9081-9100 of 15,379 trials

Predictors of Response to Treatment for Depression

NCT03154008

The current study will examine neurophysiological, specifically event-related potential (ERP), measures of emotional processing as predictors of response to cognitive behavior therapy for adolescent depression.

Adolescent DepressionDepression

Vanderbilt University Medical Center70 participantsStarted Jun 2017

Nashville, Tennessee, United States

COMPLETEDNA< 1 mile

A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation

NCT02833077

This is a safety and effectiveness study of JUVÉDERM VOLUMA XC injectable gel for chin augmentation to correct volume deficit in chin retrusion.

Chin Retrusion

Allergan221 participantsStarted Jun 2016

San Diego, California, United States • Coral Gables, Florida, United States • Miami Beach, Florida, United States +11 more locations

Predictors of Response to Treatment for Depression

A Safety and Effectiveness Study of JUVÉDERM VOLUMA® XC Injectable Gel for Chin Augmentation

Find Trials by Condition in Nashville

A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia

BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act Bold

Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.

Nilotinib in Parkinson's Disease

Daily Disposable Dispensing Clinical Trial of Test Lens Against Stenfilcon A Lens

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2

Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease

A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)

A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)